CuraSen Therapeutics, Inc.
PrivateLast Round
Series B
Aug 20, 2024
Est. Valuation
$123.5M
Total Funding Raised
$84.11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small molecule drugs to treat a broad range of psychiatric and neurodegenerative diseases, including Parkinson's and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CuraSen Therapeutics, Inc. Comparables
Compare CuraSen Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Athira Pharma | 77% | |
| Gain Therapeutics Inc | 73% | |
| AC Immune SA | 73% |
CuraSen Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 20, 2024 | ||||
| Grant | Oct 9, 2023 | ||||
| Series A Extension | Nov 5, 2021 | ||||
| Series A | Oct 17, 2018 |
CuraSen Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A |
| New Leaf Venture Partners | Series A |
| A. M. Pappas & Associates | Series A Extension, Series A |
| Tekla Capital Management | Series A |
| Chiesi Ventures | Series A Extension |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
| ICG Infra | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 55% MoM, from 1.7K to 2.7K.
- Jun 21, 2026
Monthly visitors increased 115% MoM.
CuraSen Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CuraSen Therapeutics, Inc.'s valuation, stock price, and market status.
Is CuraSen Therapeutics, Inc. a public or private company?
CuraSen Therapeutics, Inc. is a private company.
What is the current stock price of CuraSen Therapeutics, Inc.?
CuraSen Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is CuraSen Therapeutics, Inc. worth (valuation)?
Valuation information for CuraSen Therapeutics, Inc. is not publicly available.
Can I buy CuraSen Therapeutics, Inc. stock?
CuraSen Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CuraSen Therapeutics, Inc.'s last funding round?
CuraSen Therapeutics, Inc.'s most recent funding round was Strategic on October 9, 2023.
Who are the main investors in CuraSen Therapeutics, Inc.?
Key investors in CuraSen Therapeutics, Inc. include New Leaf Venture Partners.
Will CuraSen Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for CuraSen Therapeutics, Inc..
How can I track CuraSen Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CuraSen Therapeutics, Inc.'s secondary market activity and sign up for updates.